BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32585853)

  • 1. Clinical Relevance of +936 C>T
    Ballester S; Pineda B; Rodrigues P; Tormo E; Terol MJ; Eroles P
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32585853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The single-nucleotide polymorphisms +936 C/T VEGF and -710 C/T VEGFR1 are associated with breast cancer protection in a Spanish population.
    Rodrigues P; Furriol J; Tormo E; Ballester S; Lluch A; Eroles P
    Breast Cancer Res Treat; 2012 Jun; 133(2):769-78. PubMed ID: 22315135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.
    Góra-Tybor J; Szemraj J; Robak T; Jamroziak K
    Blood Cells Mol Dis; 2015 Feb; 54(2):139-43. PubMed ID: 25488616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor A (VEGFA) gene polymorphisms have an impact on survival in a subgroup of indolent patients with chronic lymphocytic leukemia.
    Lozano-Santos C; Martinez-Velasquez J; Fernandez-Cuevas B; Polo N; Navarro B; Millan I; Garcia JM; Collado R; Sanchez-Godoy P; Carbonell F; Garcia-Vela JA; Garcia-Marco JA; Gomez-Lozano N
    PLoS One; 2014; 9(6):e101063. PubMed ID: 24971577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF and bFGF gene polymorphisms in Polish patients with B-CLL.
    Wróbel T; Mazur G; Dzietczenia J; Gebura K; Kuliczkowski K; Bogunia-Kubik K
    Med Oncol; 2013 Mar; 30(1):456. PubMed ID: 23335070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.
    Karabon L; Partyka A; Jasek M; Lech-Maranda E; Grzybowska-Izydorczyk O; Bojarska-Junak A; Pawlak-Adamska E; Tomkiewicz A; Robak T; Rolinski J; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):137-145. PubMed ID: 27933341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure.
    Ravegnini G; Nannini M; Zenesini C; Simeon V; Sammarini G; Urbini M; Gatto L; Saponara M; Biasco G; Pantaleo MA; Venturoli N; Hrelia P; Angelini S
    Angiogenesis; 2017 Feb; 20(1):139-148. PubMed ID: 27896475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 promoter SNP309 is associated with an increased susceptibility to chronic lymphocytic leukemia and correlates with MDM2 mRNA expression in Chinese patients with CLL.
    Dong HJ; Fang C; Fan L; Zhu DX; Wang DM; Zhu HY; Zhuang Y; Miao KR; Liu P; Xu W; Li JY
    Int J Cancer; 2012 May; 130(9):2054-61. PubMed ID: 21647873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of VEGFA variants with altered VEGF secretion and type 2 diabetes: A case-control study.
    Sellami N; Lamine LB; Turki A; Sarray S; Jailani M; Al-Ansari AK; Ghorbel M; Mahjoub T; Almawi WY
    Cytokine; 2018 Jun; 106():29-34. PubMed ID: 29533820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.
    Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
    Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
    Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
    Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome.
    Lakkireddy S; Aula S; Kapley A; Swamy AV; Digumarti RR; Kutala VK; Jamil K
    Mol Diagn Ther; 2016 Feb; 20(1):33-44. PubMed ID: 26476544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population.
    Suwalska K; Pawlak E; Karabon L; Tomkiewicz A; Dobosz T; Urbaniak-Kujda D; Kuliczkowski K; Wolowiec D; Jedynak A; Frydecka I
    Hum Immunol; 2008 Mar; 69(3):193-201. PubMed ID: 18396212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF-3 gene polymorphisms are associated with the susceptibility to and the survival in chronic lymphocytic leukemia and could also serve as an auxiliary index.
    Zhang ZX; Shen CF; Shou LH; Fang Q
    Leuk Lymphoma; 2017 Mar; 58(3):646-654. PubMed ID: 27348780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD38 gene polymorphisms contribute to genetic susceptibility to B-cell chronic lymphocytic leukemia: evidence from two case-control studies in Polish Caucasians.
    Jamroziak K; Szemraj Z; Grzybowska-Izydorczyk O; Szemraj J; Bieniasz M; Cebula B; Giannopoulos K; Balcerczak E; Jesionek-Kupnicka D; Kowal M; Kostyra A; Calbecka M; Wawrzyniak E; Mirowski M; Kordek R; Robak T
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):945-53. PubMed ID: 19240243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Relevance of
    Villani L; Carolei A; Rosti V; Massa M; Campanelli R; Catarsi P; Abbà C; Gale RP; Barosi G
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of VEGF gene polymorphisms with sporadic Parkinson's disease in Chinese Han population.
    Wu Y; Zhang Y; Han X; Li X; Xue L; Xie A
    Neurol Sci; 2016 Dec; 37(12):1923-1929. PubMed ID: 27481110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The -137G/C Polymorphism in Interleukin-18 Gene Promoter Contributes to Chronic Lymphocytic and Chronic Myelogenous Leukemia Risk in Turkish Patients.
    Yalçın S; Mutlu P; Çetin T; Sarper M; Özgür G; Avcu F
    Turk J Haematol; 2015 Dec; 32(4):311-6. PubMed ID: 26376814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of
    Vasconcelos VCA; Lourenço GJ; Brito ABC; Vasconcelos VL; Maldaun MVC; Tedeschi H; Marie SKN; Shinjo SMO; Lima CSP
    Tumour Biol; 2019 Sep; 41(9):1010428319872092. PubMed ID: 31486713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of Associations between TLR9 and MYD88 Gene Polymorphisms and Risk of Chronic Lymphocytic Leukemia.
    Ali YB; Foad RM; Abdel-Wahed E
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3245-3250. PubMed ID: 29286214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.